Tigecycline

Brand name: Tygecil

Public Citizen has been assessing the quality and efficacy of drugs and devices since its founding in 1971. We use the law, petitions, and letters to monitor the FDA and coax the agency into action. Our actions have contributed to many drugs being pulled off the market. Public Citizen has also been instrumental in getting “black box” and other warnings on drugs. Our advocacy work on this drug is available below.

If you are interesting in reading our evaluations of the safety and efficacy of medications as well as information on drug side effects and interactions, please visit WorstPills.org.

More Information on Tigecycline (Tygecil)

• Statement: An Inexcusable Delay: FDA Finally Approves Black Box Warning for Antibiotic Tygacil, as Called for by Public Citizen, September 27, 2013
• Supplement to Petition to FDA for Tigecycline Black Box Warning, May 15, 2012
• FDA interim response to our petition on tigecycline, April 13, 2012
• Petition Requesting Black Box Warning on Tigecycline (Tygacil), October 26, 2011